SIETES :: 92006 citas

Resultados de la búsqueda por CONTRASTES YODADOS REFINAR BÚSQUEDA

1.

Anónimo. Riesgo de formación de depósitos cerebrales asociado a la administración de agentes de contraste con gadolinio. Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) 2017:1-3. [Ref.ID 101459]

2.

Whitehead KJ, Sautter NB, McWilliams JP, Chakinala MM, Merlo CA, Johnson MH, James M, Everett EM, Clancy MS, Faughnan ME, Oh SP, Olitsky SE, Pyeritz RE, Gossage JR. Effect of topical intranasal therapy on epistaxis frequency in patients with heraditary hemorrhagic telangiectasia: a randomized clinical trial. JAMA 2016;316:943-51. [Ref.ID 100742]

3.

Anónimo. Metformin-containing drugs: drug safety communication - Revised warnings for certain patients with reduced kidney function. FDA U.S. Food and Drug Administration 2016:8 de abril. [Ref.ID 100111]

4.

Hesdorffer CS, Longo DL. Drug-induced megaloblastic anemia. N Engl J Med 2015;373:1649-58. [Ref.ID 99629]

5.

Quintavalle C, Fiore D, De Micco F, Visconti G, Focaccio A, Golia B, Ricciardelli B, Donnarumma E, Bianco A, Zabatta MA, Troncone G, Colombo A, Briguori C, Condorelli G. Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury. Circulation 2012;126:3008-16. [Ref.ID 94308]

6.

Anónimo. Florbetapir 18F: approved for neuritic plaque density imaging. European Union. WHO Drug Information 2012;26:387-8. [Ref.ID 93818]

7.

Lövborg H, Eriksson LR, Jönsson AK, Bradley T, Hägg S. A prospective analysis of the preventability of adverse drug reactions reported in Sweden. Eur J Clin Pharmacol 2012;68:1183-9. [Ref.ID 93517]

8.

Chang HJ. Researchers focus on contrast safety. JAMA 2010;303:1244. [Ref.ID 88256]

9.

Khachman D, Gandia P, Sallerin F, Mailly N. Mise au point sur les réactions d'hypersensibilité immédiate et tardive aux produits de contraste iodés. Therapie 2009;64:331-9. [Ref.ID 87449]

10.

Anónimo. Metformine: encore des acidoses lactiques évitables. Prescrire 2009;29:832. [Ref.ID 87148]

11.

Lee CU, Hesley GK, Leung N, Bridges MD, Lund JT, Lee PU, Pittelkow MR. Large sample of nephrogenic systemic fibrosis cases from a single institution. Arch Dermatol 2009;145:1095-102. [Ref.ID 87068]

12.

Abujudeh HH, Kaewlai R, Kagan A, Chibnik LB, Nazarian RM, High WA, Kay J. Nephrogenic systemic fibrosis after gadopentetate dimeglumine exposure: Case series of 36 patients. Radiology 2009;253:81-9. [Ref.ID 87067]

13.

Naughton C. Drug-induced nephrotoxcicity. American Family Physician 2008;78:743-50. [Ref.ID 87065]

14.

Zoungas S, Ninomiya T, Huxley R, Cass A, Jardine M, Gallagher M, Patel A, Vasheghani-Farahani A, Sadigh G, Perkovic V. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Intern Med 2009;151:631-8. [Ref.ID 87053]

15.

Anónimo. Insuffisances rénales d'origine médicamenteuse. Prescrire 2009;29:506-10. [Ref.ID 86213]

16.

Mayor S. UK report into acute kidney injury deaths urges electrolyte checks in all emergency admissions. BMJ 2009;338:1407. [Ref.ID 86059]

17.

Baid SK, Lai EW, Wesley RA, Ling A, Timmers HJLM, Adams KT, Kozupa A, Pacak K. Brief communication: radiographic contrast infusion and catecholamine release in patients with pheochromocytoma. Ann Intern Med 2009;150:27-32. [Ref.ID 85011]

18.

Maioli M, Toso A, Leoncini M, Gallopin M, Tedeschi D, Micheletti C, Bellandi F. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol 2008;52:599-604. [Ref.ID 84029]

19.

Lapi F, Cecchi E, Pedone C, Attanasio F, Banchelli G, Vannacci A, Di Pirro M, Moschini M, Berni V, Matucci R, Cini E, Scalia A, Tendi E, Mugelli A. Safety aspects of iodinated contrast media related to their psychochemical properties: a pharmacoepidemiology study in two Tuscany hospitals. Eur J Clin Pharmacol 2008;64:723-37. [Ref.ID 83517]

20.

Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med 2008;148:284-94. [Ref.ID 82249]